ACE inhibitors and chronotherapy

被引:25
作者
Ohmori, M [1 ]
Fujimura, A [1 ]
机构
[1] Jichi Med Sch, Dept Pharmacol, Div Clin Pharmacol, Minami Kawachi, Tochigi 3290498, Japan
关键词
ACE inhibitors; surrogate endpoint; cardiac hypertrophy; chronotherapy; drug-induced dry cough; primary endpoint; blood pressure;
D O I
10.1081/CEH-200048762
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronotherapy can improve the effectiveness and reduce the adverse reactions of drugs and actually is used for several conditions including cardiovascular diseases. Although angiotensin converting enzyme (ACE) inhibitors are available for the therapy of patients with hypertension and/or heart failure, these agents have some characteristic adverse effects such as angioedema and dry cough. It has been reported that the dosing of ACE inhibitor at an inactive period has a better protective effect against cardiac hypertrophy in hypertensive rats, and changing dosing time from morning to evening reduces the severity and frequency of the drug-induced dry cough of hypertensive patients treated in the morning. Thus, the dosing of ACE inhibitors in the inactive span is more effective and safe. Dosing in the evening may be an alternative for hypertensives with dry cough with a morning dose of ACE inhibitors, if one ascertains that no circadian hyperamplitude tension is induced by the evening dose of this or any other antihypertensive drug.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 32 条
[1]   Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients [J].
Arakawa, M ;
Sasaki, M ;
Ohmori, M ;
Harada, K ;
Fujimura, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (11) :775-779
[2]   DIURNAL-VARIATIONS OF BLOOD-PRESSURE AND MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION [J].
BIANCHI, S ;
BIGAZZI, X ;
BALDARI, G ;
SGHERRI, G ;
CAMPESE, VM .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (01) :23-29
[3]   Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].
Black, HR ;
Elliott, WJ ;
Grandits, G ;
Grambsch, P ;
Lucente, T ;
White, WB ;
Neaton, JD ;
Grimm, RH ;
Hansson, L ;
Lacourcière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Anders, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082
[4]   Circadian rhythms in the pharmacokinetics and clinical effects of beta-agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma [J].
D'Alonzo, GE ;
Crocetti, JG ;
Smolensky, MH .
CHRONOBIOLOGY INTERNATIONAL, 1999, 16 (05) :663-682
[5]   TIME-DEPENDENT CHANGE IN THE EFFECT OF PROBUCOL IN SUBJECTS WITH ELEVATED CHOLESTEROL [J].
FUJIMURA, A ;
OHASHI, K ;
EBIHARA, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) :299-301
[6]  
Fujimura A., 1999, JPN J CLIN PHARM THE, V30, P741, DOI 10.3999/jscpt.30.741
[7]  
GREGOIRE JP, 1999, CAN J CARDIOL SF, V15, P39
[8]   Clinical significance of nocturnal blood pressure monitoring [J].
Imai, Y ;
Ohkubo, T ;
Tsuji, I ;
Satoh, H ;
Hisamichi, S .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (5-6) :717-727
[9]   DIURNAL-VARIATION IN THE PHARMACOKINETICS OF NIZATIDINE IN HEALTHY-VOLUNTEERS AND IN PATIENTS WITH PEPTIC-ULCER DISEASE [J].
JAMALI, F ;
THOMSON, ABR ;
KIRDEIKIS, P ;
TAVERNINI, M ;
ZUK, L ;
MARRIAGE, B ;
SIMPSON, I ;
MAHACHAI, V .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (11) :1071-1075
[10]  
JONES JK, 1994, BMJ-BRIT MED J, V311, P293